This website, owned by Alantra Partners S.A., uses cookies, including third-party cookies, to better understand how you use our website, offer better functionality and customization levels. For more information on how we use cookies, please see our Cookie Policy. Please, configure your cookie preferences or accept them all to continue navigating in our website.
Config Accept
Search

What we do / Investment Banking / Transactions / Alantra advised the recommended Cash Offer for Cyprotex by Evotec AG for £41.7 million

Alantra advised the recommended Cash Offer for Cyprotex by Evotec AG for £41.7 million

SECTORHealthcare

ServiceM&A

Value £41.7 million

Oct 2016
Sell-side advisory
Value £41.7 million
View Equity Capital Markets View Healthcare View The United Kingdom

Related Transactions

View All